Alicia Grande - Net Worth and Insider Trading

Alicia Grande Net Worth

The estimated net worth of Alicia Grande is at least $764,927 dollars as of 2024-04-19. Alicia Grande is the VP, Treasurer and CFO of Catalyst Pharmaceuticals Inc and owns about 50,557 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $764,927. Details can be seen in Alicia Grande's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alicia Grande has not made any transactions after 2023-12-11 and currently still holds the listed stock(s).

Transaction Summary of Alicia Grande

To

Alicia Grande Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alicia Grande owns 1 companies in total, including Catalyst Pharmaceuticals Inc () .

Click here to see the complete history of Alicia Grande’s form 4 insider trades.

Insider Ownership Summary of Alicia Grande

Ticker Comapny Transaction Date Type of Owner
Catalyst Pharmaceuticals Inc 2023-12-11 Chief Accounting Officer

Alicia Grande Latest Holdings Summary

Alicia Grande currently owns a total of 1 stock. Alicia Grande owns 50,557 shares of Catalyst Pharmaceuticals Inc (CPRX) as of December 11, 2023, with a value of $764,927.

Latest Holdings of Alicia Grande

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2023-12-11 50,557 15.13 764,927

Holding Weightings of Alicia Grande


Alicia Grande Form 4 Trading Tracker

According to the SEC Form 4 filings, Alicia Grande has made a total of 11 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 100,000 shares on December 11, 2023, which brought Alicia Grande around $1 Million.

Insider Trading History of Alicia Grande

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alicia Grande Trading Performance

GuruFocus tracks the stock performance after each of Alicia Grande's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alicia Grande is 118.25%. GuruFocus also compares Alicia Grande's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alicia Grande within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alicia Grande's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alicia Grande

Average Return

62.23%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 52.52 118.25 19.22 62.23 78.29 59.06
Relative Return to S&P 500(%) 50.63 113.76 13.93 44.52 62.75 45.71

Alicia Grande Ownership Network

Ownership Network List of Alicia Grande

No Data

Ownership Network Relation of Alicia Grande


Alicia Grande Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Alicia Grande is the Chief Accounting Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Medical Officer Gary Ingenito , and VP Development & Management Steve Miller .

Catalyst Pharmaceuticals Inc () Insider Trades Summary

Over the past 18 months, Alicia Grande made 5 insider transaction in Catalyst Pharmaceuticals Inc () with a net sale of 430,000. Other recent insider transactions involving Catalyst Pharmaceuticals Inc () include a net sale of 105,000 shares made by David S Tierney , a net sale of 89,666 shares made by Brian Elsbernd , and a net sale of 526,151 shares made by Patrick J Mcenany .

In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.

Catalyst Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Alicia Grande Mailing Address

Above is the net worth, insider trading, and ownership report for Alicia Grande. You might contact Alicia Grande via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.

Discussions on Alicia Grande

No discussions yet.